Cargando…
Low Concentration of Rapamycin Inhibits Hemangioma Endothelial Cell Proliferation, Migration, and Vascular Tumor Formation in Mice
BACKGROUND: Vascular endothelial cell excessive proliferation is the main biological behavior of hemangioma. Rapamycin regulates the growth of endothelial cells by inhibiting mammalian target of rapamycin (mTOR). Thus hemangioma accompanied by excessive mTOR activation should be sensitive to rapamyc...
Autores principales: | Zheng, Ningning, Ding, Xudong, Jahan, Rabita |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4229512/ https://www.ncbi.nlm.nih.gov/pubmed/25408787 http://dx.doi.org/10.1016/j.curtheres.2014.09.004 |
Ejemplares similares
-
Concentration-dependent effects of rapamycin on proliferation, migration and apoptosis of endothelial cells in human venous malformation
por: Si, Yameng, et al.
Publicado: (2018) -
Retraction: Rapamycin Inhibits Proliferation of Hemangioma Endothelial Cells by Reducing HIF-1-Dependent Expression of VEGF
Publicado: (2020) -
Urea immunoliposome inhibits human vascular endothelial cell proliferation for hemangioma treatment
por: Wang, Zhiliang, et al.
Publicado: (2013) -
The effects of rapamycin on lens epithelial cell proliferation, migration, and matrix formation: An in vitro study
por: Liu, Hongling, et al.
Publicado: (2010) -
Effect of silencing lncRNATUG1 on rapamycin-induced inhibition of endothelial cell proliferation and migration
por: Gao, Xue, et al.
Publicado: (2018)